The pharma company's shares are getting crushed after regulators decline to green light a drug to treat a rare disease.

Investors profiled retail giants as Adobe predicts a record $10.8 billion in online purchases. Chip and crypto stocks rose, ...

U.S. stocks anticipate a slight rise on Black Friday as the holiday shopping season begins. Retailers are in focus with an ...

Applied Therapeutics' stock plummeted 75 percent after the Food and Drug Administration (FDA) rejected approving govorestat ...

Wall Street's main indexes opened slightly higher in a shortened Black Friday trading session, on track for monthly gains as ...

Applied Therapeutics ( APLT, Financials) announced that the U.S. Food and Drug Administration issued a Complete Response ...

Uruguay's ex-president Jose Mujica, who at 89 is an icon for leftists across Latin America, hailed the return of the left to power in his country's weekend elections as a "farewell gift." ...

Applied Therapeutics' (APLT) lead drug candidate, govorestat, likely faces "significant" uncertainty in potentially treating galactosemia after the US Food and Drug Administration rejected the ...

Swiss private bank Lombard Odier has been charged with money laundering following an investigation linked to a corruption case against Gulnara Karimova, the daughter of Uzbekistan's former president, ...

U.S. equities headed to Friday's early close—and the conclusion of November trading—in positive territory as the ...

Applied Therapeutics' New Drug Application for a rare metabolic disease was rejected by the Food and Drug Administration, ...

智通财经APP获悉，周五，Applied Therapeutics ...